Importantly, we found that induction of KRASG12D expression led to a significant decrease in SIRT3 expression (Fig. 2), suggesting that down-regulation of SIRT3 by KRAS might be a mechanism that facilitates KRAS-driven pancreatic cancer development. Here, KRAS is linked to pancreatic neoplasm.